Eric Joseph
Stock Analyst at JP Morgan
(2.04)
# 2,873
Out of 4,732 analysts
126
Total ratings
40%
Success rate
-7.99%
Average return
Main Sectors:
Stocks Rated by Eric Joseph
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IGMS IGM Biosciences | Upgrades: Neutral | n/a | $1.77 | - | 8 | Jan 13, 2025 | |
| VIR Vir Biotechnology | Maintains: Neutral | $10 → $14 | $10.11 | +38.48% | 5 | Jan 9, 2025 | |
| RVMD Revolution Medicines | Maintains: Overweight | $63 → $71 | $40.29 | +76.22% | 6 | Dec 3, 2024 | |
| TGTX TG Therapeutics | Maintains: Overweight | $30 → $43 | $29.55 | +45.52% | 4 | Nov 25, 2024 | |
| PTCT PTC Therapeutics | Maintains: Overweight | $51 → $62 | $43.84 | +41.42% | 6 | Nov 19, 2024 | |
| SEPN Septerna | Initiates: Overweight | $38 | $16.89 | +124.99% | 1 | Nov 19, 2024 | |
| CAMP Camp4 Therapeutics | Initiates: Overweight | $23 | $4.62 | +397.84% | 1 | Nov 5, 2024 | |
| WVE Wave Life Sciences | Maintains: Overweight | $13 → $17 | $10.99 | +54.69% | 2 | Oct 17, 2024 | |
| RLAY Relay Therapeutics | Maintains: Overweight | $23 → $21 | $4.46 | +370.85% | 5 | Sep 10, 2024 | |
| BLUE bluebird bio | Downgrades: Neutral | n/a | $8.35 | - | 2 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $8 → $9 | $8.40 | +7.14% | 7 | Aug 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $45 → $48 | $23.44 | +104.78% | 3 | Aug 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $11 → $10 | $5.25 | +90.48% | 4 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $50 → $54 | $10.31 | +423.76% | 2 | Aug 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $34 | $19.14 | +77.64% | 6 | Jul 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.90 | - | 4 | Jul 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $16 → $15 | $2.89 | +419.03% | 4 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $14 → $15 | $3.98 | +277.36% | 1 | May 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 → $47 | $40.61 | +15.74% | 2 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $6 | $3.94 | +52.28% | 4 | Jan 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $11 → $10 | $6.53 | +53.14% | 2 | Nov 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $31 → $11 | $5.66 | +94.52% | 2 | Oct 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $62 → $41 | $25.14 | +63.09% | 2 | Oct 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $15 → $5 | $0.58 | +768.81% | 1 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $28 → $5 | $0.91 | +449.87% | 2 | Aug 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $47 → $48 | $11.21 | +328.19% | 3 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $3.37 | - | 6 | Aug 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $10 → $11 | $4.43 | +148.31% | 6 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $12.08 | - | 2 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $8 | $0.66 | +1,111.94% | 2 | Feb 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $750 → $300 | $34.24 | +776.17% | 2 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $9.33 | - | 2 | Oct 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $50 | $6.14 | +714.33% | 1 | Jul 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underweight | $11 | $1.14 | +864.91% | 1 | Apr 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $24 → $9 | $2.22 | +305.41% | 2 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $2.07 | - | 4 | Jan 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Overweight | $42 | $2.20 | +1,809.09% | 1 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Neutral | $11 → $13 | $3.66 | +255.19% | 2 | Jan 24, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $35 → $11 | $1.09 | +909.17% | 3 | Nov 14, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | n/a | $1.47 | - | 3 | Mar 2, 2018 |
IGM Biosciences
Jan 13, 2025
Upgrades: Neutral
Price Target: n/a
Current: $1.77
Upside: -
Vir Biotechnology
Jan 9, 2025
Maintains: Neutral
Price Target: $10 → $14
Current: $10.11
Upside: +38.48%
Revolution Medicines
Dec 3, 2024
Maintains: Overweight
Price Target: $63 → $71
Current: $40.29
Upside: +76.22%
TG Therapeutics
Nov 25, 2024
Maintains: Overweight
Price Target: $30 → $43
Current: $29.55
Upside: +45.52%
PTC Therapeutics
Nov 19, 2024
Maintains: Overweight
Price Target: $51 → $62
Current: $43.84
Upside: +41.42%
Septerna
Nov 19, 2024
Initiates: Overweight
Price Target: $38
Current: $16.89
Upside: +124.99%
Camp4 Therapeutics
Nov 5, 2024
Initiates: Overweight
Price Target: $23
Current: $4.62
Upside: +397.84%
Wave Life Sciences
Oct 17, 2024
Maintains: Overweight
Price Target: $13 → $17
Current: $10.99
Upside: +54.69%
Relay Therapeutics
Sep 10, 2024
Maintains: Overweight
Price Target: $23 → $21
Current: $4.46
Upside: +370.85%
bluebird bio
Aug 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $8.35
Upside: -
Aug 12, 2024
Maintains: Underweight
Price Target: $8 → $9
Current: $8.40
Upside: +7.14%
Aug 7, 2024
Maintains: Overweight
Price Target: $45 → $48
Current: $23.44
Upside: +104.78%
Aug 6, 2024
Maintains: Underweight
Price Target: $11 → $10
Current: $5.25
Upside: +90.48%
Aug 6, 2024
Maintains: Overweight
Price Target: $50 → $54
Current: $10.31
Upside: +423.76%
Jul 15, 2024
Maintains: Overweight
Price Target: $31 → $34
Current: $19.14
Upside: +77.64%
Jul 8, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.90
Upside: -
May 13, 2024
Maintains: Overweight
Price Target: $16 → $15
Current: $2.89
Upside: +419.03%
May 3, 2024
Maintains: Neutral
Price Target: $14 → $15
Current: $3.98
Upside: +277.36%
Feb 23, 2024
Maintains: Overweight
Price Target: $34 → $47
Current: $40.61
Upside: +15.74%
Jan 29, 2024
Upgrades: Neutral
Price Target: $6
Current: $3.94
Upside: +52.28%
Nov 13, 2023
Maintains: Neutral
Price Target: $11 → $10
Current: $6.53
Upside: +53.14%
Oct 19, 2023
Maintains: Overweight
Price Target: $31 → $11
Current: $5.66
Upside: +94.52%
Oct 11, 2023
Maintains: Overweight
Price Target: $62 → $41
Current: $25.14
Upside: +63.09%
Aug 28, 2023
Downgrades: Neutral
Price Target: $15 → $5
Current: $0.58
Upside: +768.81%
Aug 28, 2023
Downgrades: Neutral
Price Target: $28 → $5
Current: $0.91
Upside: +449.87%
Aug 10, 2023
Maintains: Overweight
Price Target: $47 → $48
Current: $11.21
Upside: +328.19%
Aug 10, 2023
Downgrades: Underweight
Price Target: n/a
Current: $3.37
Upside: -
Aug 9, 2023
Maintains: Neutral
Price Target: $10 → $11
Current: $4.43
Upside: +148.31%
Nov 29, 2022
Downgrades: Underweight
Price Target: n/a
Current: $12.08
Upside: -
Feb 9, 2022
Upgrades: Neutral
Price Target: $8
Current: $0.66
Upside: +1,111.94%
Jan 7, 2022
Downgrades: Neutral
Price Target: $750 → $300
Current: $34.24
Upside: +776.17%
Oct 8, 2021
Downgrades: Underweight
Price Target: n/a
Current: $9.33
Upside: -
Jul 12, 2021
Initiates: Neutral
Price Target: $50
Current: $6.14
Upside: +714.33%
Apr 26, 2021
Initiates: Underweight
Price Target: $11
Current: $1.14
Upside: +864.91%
Jan 29, 2021
Downgrades: Neutral
Price Target: $24 → $9
Current: $2.22
Upside: +305.41%
Jan 29, 2021
Downgrades: Underweight
Price Target: n/a
Current: $2.07
Upside: -
Feb 24, 2020
Initiates: Overweight
Price Target: $42
Current: $2.20
Upside: +1,809.09%
Jan 24, 2019
Upgrades: Neutral
Price Target: $11 → $13
Current: $3.66
Upside: +255.19%
Nov 14, 2018
Maintains: Neutral
Price Target: $35 → $11
Current: $1.09
Upside: +909.17%
Mar 2, 2018
Downgrades: Underweight
Price Target: n/a
Current: $1.47
Upside: -